Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
It is administered by a qualified healthcare professional through injection as prescribed by your doctor
The peptide can bind to both glucagon receptor and GLP-1 receptor
LY3437943 (Retatrutide): discovery to clinical proof of concept (triple GLP-1/GIP/glucagon agonist, preclinical mechanism) Nature Reviews Endocrinology (2024) Multi-receptor agonists for metabolic disease (mechanism of GLP-1/GIP/glucagon co-activation) Diabetes Care (2024) Incretin-based therapies: GLP-1, GIP, and glucagon receptor pharmacology (metabolic pathways, energy expenditure) NEJM (2023) Supplementary Material Jastreboff et al
There is limited evidence regarding the relationship between high vitamin B12 levels and blood sugar regulation
When combined with the gut-fortifying properties of BPC-157, this shows promise as a formidable treatment for diseases of the GI tract , including perianal fistulas
